Inhibition of accelerated atherosclerosis in vein grafts by placement of external stent in ApoE*3 Leiden transgenic mice

被引：0
|
作者：
Lardenoye, JWH
De Vries, M
Van Bockel, H
Van Hinsbergh, V
Quax, P
机构：
[1] TNO, IVVO, Gaubius Lab, NL-2300 AK Leiden, Netherlands
[2] TNO Prevent & Hlth, Leiden, Netherlands
[3] Leiden Univ, Med Ctr, Dept Vasc Surg, Leiden, Netherlands
来源：
CIRCULATION | 2001年 / 104卷 / 17期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
3362
引用
收藏
页码：713 / 713
页数：1
相关论文
共 50 条
  • [11] Enhanced atherosclerosis in macrophage scavenger receptor deficient APOE3Leiden transgenic mice
    deWinther, MPJ
    Gijbels, MJJ
    VanDijk, KW
    vanGorp, PJJ
    Kodama, T
    Frants, RR
    Havekes, LM
    Hofker, MH
    CIRCULATION, 1997, 96 (08) : 2743 - 2743
  • [12] Olmesartan and pravastatin additively reduce development of atherosclerosis in APOE*3Leiden transgenic mice
    van der Hoorn, Jose W. A.
    Kleemann, Robert
    Havekes, Louis M.
    Kooistra, Teake
    Princen, Hans M. G.
    Jukema, J. Wouter
    JOURNAL OF HYPERTENSION, 2007, 25 (12) : 2454 - 2462
  • [13] Tesaglitazar, a dual PPARα/γ agonist, reduces atherosclerosis in APOE*3Leiden transgenic mice
    Havekes, LM
    Zadelaar, SM
    Boesten, LSM
    Jukema, WJ
    Van Vlijmen, BJM
    Lundholm, E
    Camejo, G
    DIABETES, 2005, 54 : A233 - A234
  • [14] INHIBITION OF GLYCOSPHINGOLIPID SYNTHESIS STRONGLY REDUCES ATHEROSCLEROSIS DEVELOPMENT IN APOE*3 LEIDEN MICE
    Bietrix, F.
    Lombardo, E.
    van Roomen, C.
    Ottenhoff, R.
    Groen, A.
    Aerts, J.
    ATHEROSCLEROSIS SUPPLEMENTS, 2009, 10 (02)
  • [15] Atherosclerotic lesions in ApoE3-Leiden transgenic mice
    Leppanen, P
    Luoma, J
    Hofker, M
    Havekes, L
    YlaHerttuala, S
    ATHEROSCLEROSIS, 1997, 134 (1-2) : 34 - 35
  • [16] Differential effects of amlodipine and atorvastatin treatment and their combination on atherosclerosis in ApoE*3-Leiden transgenic mice
    Delsing, DJM
    Jukema, JW
    van de Wiel, MA
    Emeis, JJ
    van der Laarse, A
    Havekes, LM
    Princen, HMG
    JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 2003, 42 (01) : 63 - 70
  • [17] Inhibition of complement component C3 reduces vein graft atherosclerosis in apolipoprotein E3-Leiden transgenic mice
    Schepers, A.
    de Vries, M. R.
    van Leuven, C. J.
    Grimbergen, J. M.
    Holers, V. M.
    Daha, M. R.
    van Bockel, J. H.
    Quax, P. H. A.
    CIRCULATION, 2006, 114 (25) : 2831 - 2838
  • [18] Macrophage p53 deficiency leads to enhanced atherosclerosis in APOE*3-Leiden transgenic mice
    van Vlijmen, BJM
    Gerritsen, G
    Franken, AL
    Boesten, SM
    Kockx, MM
    Gijbels, MJ
    Vierboom, MP
    van Eck, M
    van de Water, B
    van Berkel, TJC
    Havekes, LM
    CIRCULATION RESEARCH, 2001, 88 (08) : 780 - 786
  • [19] Quantitative assessment of aortic atherosclerosis in APOE*3 Leiden transgenic mice and its relationship to serum cholesterol exposure
    Groot, PHE
    vanVlijmen, BJM
    Benson, GM
    Hofker, MH
    Schiffelers, R
    VidgeonHart, M
    Havekes, LM
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 1996, 16 (08) : 926 - 933
  • [20] THE EFFECT OF ALISKIREN ON ATHEROSCLEROSIS DEVELOPMENT IN APOE*3LEIDEN.CETP TRANSGENIC MICE WITH AND WITHOUT TREATMENT WITH ATORVASTATIN
    Jordaan, S.
    van der Hoorn, J. W. A.
    Havekes, L. M.
    Liau, G.
    Jukema, J. W.
    Princen, H. M. G.
    ATHEROSCLEROSIS SUPPLEMENTS, 2010, 11 (02) : 31 - 31
12345